Explore more Articles in

Stock Sectors

June Payrolls Jump, but Other Growth Indicators Paint a Sluggish Picture

June beats consensus on the back of education and health services employment, while private NFP surprises downside. With S&P Global monthly flat...

Fed Gets Breathing Room as Labor Market Holds Firm

The monthly jobs report hit today (unusually, on a Thursday, due to the real and perfectly sensible holiday tomorrow blocking the typical Friday release)...

How California’s Housing Reforms Could Reshape US Cities Over the Next Decade

Things are moving fast these days. Texans for Reasonable Solutions, among others, has helped push through a number of housing reforms in Texas. Maine has passed...

Week Ahead – RBA, RBNZ Decisions and Fed Minutes Eyed as Trade Deals Awaited

July 9 tariff deadline looms as trade deals remain elusive Fed minutes to be watched after positive jobs report RBA expected to cut but RBNZ to...

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions

Immuthera's Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy SolutionsDistinguished experts Dr. Jay Skyler, Dr. Desmond Schatz, and Dr. Lawrence Steinman have...

Oil Prices Set to End the Week With a Modest Gain

prices were on course for a modest weekly gain today, buffeted by both headwinds and tailwinds, including OPEC+ policy, U.S. job numbers, and...

Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer’s Trial Data – Cognition Therapeutics (NASDAQ:CGTX), InMed Pharmaceuticals (NASDAQ:INM)

Cognition Therapeutics Inc CGTX rose 12.10% to $0.45 during after hours on Thursday, following a surge of 20.82% gain during regular hours. What Happened: The...

Oil: How Traders Capitalized on Extreme Price Swings

The first half of the year saw significant oil price volatility influenced by U.S. trade policies, OPEC+ production decisions, and geopolitical tensions. Oil prices initially...

Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns – Beta Bionics (NASDAQ:BBNX), Cognition Therapeutics (NASDAQ:CGTX)

Sonnet BioTherapeutics Holdings Inc. SONN stock experienced a drop of 5.54% on Thursday, followed by a remarkable recovery of 14.29% in after-hours trading.What Happened:...

AstraZeneca In $15 Billion Talks For Drug That Could Upend Lung Cancer Treatment – AstraZeneca (NASDAQ:AZN), Summit Therapeutics (NASDAQ:SMMT)

In a high-stakes maneuver that could reshape the oncology landscape, AstraZeneca Plc AZN is reportedly in talks with Summit Therapeutics Inc. SMMT about a...

- A word from our sponsors -

Most Popular